End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7,45,000 KRW | -1.32% | -5.70% | -1.97% |
23/05 | US FDA Approves Samsung Bioepis' Eye Disease Drug Opuviz | MT |
06/05 | Samsung Group Firms Set to Invest in US-based Latus Bio | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.97% | 3.95TCr | |
-1.64% | 9.03TCr | |
-15.47% | 3.17TCr | |
+61.28% | 2.64TCr | |
-22.81% | 1.43TCr | |
-8.82% | 1.29TCr | |
-11.77% | 1.18TCr | |
-45.97% | 1.1TCr | |
+3.30% | 884.67Cr | |
-13.92% | 753.35Cr |
- Stock Market
- Equities
- A207940 Stock
- News Samsung Biologics Co.,Ltd.
- Samsung Biologics Posts Higher Q1 Profit, Sales